Shell Asset Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $78K | Sell |
|
|||||
|
2023
Q3 | $75K | Sell |
|
|||||
|
2023
Q2 | $64K | Sell |
|
|||||
|
2023
Q1 | $66K | Sell |
|
|||||
|
2022
Q4 | $80K | Sell |
|
|||||
|
2022
Q3 | $149K | Sell |
|
|||||
|
2022
Q2 | $181K | Buy |
|
|||||
|
2022
Q1 | $221K | Sell |
|
|||||
|
2021
Q4 | $453K | Buy |
|
|||||
|
2021
Q3 | $542K | Sell |
|
|||||
|
2021
Q2 | $518K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $321K | Hold |
|
|||||
|
2020
Q3 | $243K | Hold |
|
|||||
|
2020
Q2 | $167K | Buy |
|